Australia's Vitrafy Life Sciences slumps on discounted placement

Vitrafy Life Sciences

12/06/2026 06:30

** Shares of Vitrafy Life Sciences VFY.AX fall as much as 21.3% to A$2.99, marking their biggest pct loss ever
** Cryopreservation solution developer announces A$30 million ($21.11 million) institutional placement at A$2.60 per share, a 46.2% discount to last close 
** About 245,052 shares traded so far, 4.3x 30-day average
** Stock last down 13.7% with YTD gains of 156.3%
($1 = 1.4211 Australian dollars)

(Reporting by Subhalakshmi Dey in Bengaluru)
((subhalakshmi.dey@thomsonreuters.com;))